Cassava Sciences, Inc. (NASDAQ: SAVA) reported Q4 EPS of ($0.57), $0.09 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Cassava Sciences, Inc. (SAVA) click here.